SB 5371 – Washington
Status: Inactive / DeadYear Introduced: 2019
Link: https://app.leg.wa.gov/billsummary?BillNumber=5371&Year=2019&initiative=
PROTECTING CONSUMERS AND PURCHASERS FROM EXCESSIVE INCREASES IN INSULIN DRUG PRICES. If a drug manufacturer increases the wholesale acquisition cost of an insulin drug by ten percent at any one time or in the aggregate in any twelve-month period, the drug manufacturer must use the price increase notification form established under section 4 of this act to notify the office of the insurance commissioner and the health care authority prescription drug program of the increase.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found